Skip to main content
Erschienen in: Spektrum der Augenheilkunde 6/2014

01.12.2014 | original article

Causes of sterile vitritis in the setting of Boston keratoprosthesis

verfasst von: Christina M. Grassi, James Chodosh, MD, MPH

Erschienen in: Spektrum der Augenheilkunde | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Summary

An idiopathic inflammation of the vitreous humor, “sterile vitritis”, has been observed in some keratoprosthesis recipients, typically months to years after implantation. Its etiology is unclear. Potential mechanisms include: (i) local tissue destruction and inflammation around the prosthesis, at the point of contact between cornea donor tissue and the device, (ii) microbial cell wall or nucleic acid triggering inflammation, and (iii) a systemic immune response with ocular manifestations.
One or more of these mechanisms likely contributes to each case of idiopathic vitreous inflammation. Tissue remodeling around the keratoprosthesis may create a dynamic space for inorganic or organic debris to enter the eye. Some cases of vitritis may have an infectious origin, despite negative cultures. Continued studies are needed to assess the clinical significance of corneal tissue loss under the front plate and adjacent to the stem. These areas of tissue “gaps” may provide access for organic and inorganic debris to enter the eye and stimulate inflammation.
Literatur
1.
Zurück zum Zitat Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640–51.PubMedCrossRef Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640–51.PubMedCrossRef
2.
Zurück zum Zitat Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119(8):1530–8.PubMedCrossRef Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119(8):1530–8.PubMedCrossRef
3.
Zurück zum Zitat Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the university of california davis experience. Cornea. 2009;28(3):321–7.PubMedCrossRef Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the university of california davis experience. Cornea. 2009;28(3):321–7.PubMedCrossRef
4.
Zurück zum Zitat Zerbe BL, Belin MW, Ciolino JB, Group BTKS. Results from the multicenter Boston Type 1 Keratoprosthesis study. Ophthalmology. 2006;113(10):1779.e1–7. Zerbe BL, Belin MW, Ciolino JB, Group BTKS. Results from the multicenter Boston Type 1 Keratoprosthesis study. Ophthalmology. 2006;113(10):1779.e1–7.
5.
6.
Zurück zum Zitat Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull. 2010;81(2–3):219–28.PubMedCrossRef Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull. 2010;81(2–3):219–28.PubMedCrossRef
7.
Zurück zum Zitat Ueta M, Kinoshita S. Ocular surface inflammation mediated by innate immunity. Eye Contact Lens. 2010;36(5):269–81.PubMedCrossRef Ueta M, Kinoshita S. Ocular surface inflammation mediated by innate immunity. Eye Contact Lens. 2010;36(5):269–81.PubMedCrossRef
8.
Zurück zum Zitat Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24(8):915–9.PubMedCrossRef Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24(8):915–9.PubMedCrossRef
9.
Zurück zum Zitat Gautam R, Singh RD, Sharma VP, Siddhartha R, Chand P, Kumar R. Biocompatibility of polymethylmethacrylate resins used in dentistry. J Biomed Mater Res B Appl Biomater. 2012;100(5):1444–50.PubMedCrossRef Gautam R, Singh RD, Sharma VP, Siddhartha R, Chand P, Kumar R. Biocompatibility of polymethylmethacrylate resins used in dentistry. J Biomed Mater Res B Appl Biomater. 2012;100(5):1444–50.PubMedCrossRef
10.
Zurück zum Zitat Lloyd AW, Faragher RG, Denyer SP. Ocular biomaterials and implants. Biomaterials. 2001;22(8):769–85.PubMedCrossRef Lloyd AW, Faragher RG, Denyer SP. Ocular biomaterials and implants. Biomaterials. 2001;22(8):769–85.PubMedCrossRef
11.
Zurück zum Zitat Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res. 2008;10(3):166–73.PubMedCrossRef Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res. 2008;10(3):166–73.PubMedCrossRef
12.
Zurück zum Zitat Nowzari H, Yi K, Chee W, Rich SK. Immunology, microbiology, and virology following placement of NobelPerfect scalloped dental implants: analysis of a case series. Clin Implant Dent Relat Res. 2008;10(3):157–65.PubMedCrossRef Nowzari H, Yi K, Chee W, Rich SK. Immunology, microbiology, and virology following placement of NobelPerfect scalloped dental implants: analysis of a case series. Clin Implant Dent Relat Res. 2008;10(3):157–65.PubMedCrossRef
13.
Zurück zum Zitat Gratton DG, Aquilino SA, Stanford CM. Micromotion and dynamic fatigue properties of the dental implant-abutment interface. J Prosthet Dent. 2001;85(1):47–52.PubMedCrossRef Gratton DG, Aquilino SA, Stanford CM. Micromotion and dynamic fatigue properties of the dental implant-abutment interface. J Prosthet Dent. 2001;85(1):47–52.PubMedCrossRef
14.
Zurück zum Zitat Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, et al. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res. 1997;76(9):1529–37.PubMedCrossRef Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, et al. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res. 1997;76(9):1529–37.PubMedCrossRef
15.
Zurück zum Zitat Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol. 2011;33(3):295–306.PubMedCrossRef Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol. 2011;33(3):295–306.PubMedCrossRef
16.
Zurück zum Zitat Howes EL, Cole PW, Adair TM, Cruse VK, Pollycove M. Cellular and vascular responses in acute experimental ocular inflammation. Invest Ophthalmol Vis Sci. 1994;35(12):4031–8.PubMed Howes EL, Cole PW, Adair TM, Cruse VK, Pollycove M. Cellular and vascular responses in acute experimental ocular inflammation. Invest Ophthalmol Vis Sci. 1994;35(12):4031–8.PubMed
17.
Zurück zum Zitat Long M, Rack HJ. Titanium alloys in total joint replacement-a materials science perspective. Biomaterials. 1998;19(18):1621–39.PubMedCrossRef Long M, Rack HJ. Titanium alloys in total joint replacement-a materials science perspective. Biomaterials. 1998;19(18):1621–39.PubMedCrossRef
18.
Zurück zum Zitat Rajpura A, Kendoff D, Board TN. The current state of bearing surfaces in total hip replacement. Bone Joint J. 2014;96-B(2):147–56.PubMedCrossRef Rajpura A, Kendoff D, Board TN. The current state of bearing surfaces in total hip replacement. Bone Joint J. 2014;96-B(2):147–56.PubMedCrossRef
20.
Zurück zum Zitat Heuer W, Elter C, Demling A, Neumann A, Suerbaum S, Hannig M, et al. Analysis of early biofilm formation on oral implants in man. J Oral Rehabil. 2007;34(5):377–82.PubMedCrossRef Heuer W, Elter C, Demling A, Neumann A, Suerbaum S, Hannig M, et al. Analysis of early biofilm formation on oral implants in man. J Oral Rehabil. 2007;34(5):377–82.PubMedCrossRef
21.
Zurück zum Zitat Iyer G, Pillai VS, Srinivasan B, Falcinelli G, Padmanabhan P, Guruswami S. Modified osteo-odonto keratoprosthesis-the Indian experience-results of the first 50 cases. Cornea. 2010;29(7):771–6.PubMed Iyer G, Pillai VS, Srinivasan B, Falcinelli G, Padmanabhan P, Guruswami S. Modified osteo-odonto keratoprosthesis-the Indian experience-results of the first 50 cases. Cornea. 2010;29(7):771–6.PubMed
22.
Zurück zum Zitat Huang Y, Yu J, Liu L, Du G, Song J, Guo H. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing. Ophthalmology. 2011;118(1):41–6.PubMedCrossRef Huang Y, Yu J, Liu L, Du G, Song J, Guo H. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing. Ophthalmology. 2011;118(1):41–6.PubMedCrossRef
23.
Zurück zum Zitat Tan XW, Riau A, Shi ZL, Tan AC, Neoh KG, Khor KA, et al. In vitro effect of a corrosive hostile ocular surface on candidate biomaterials for keratoprosthesis skirt. Br J Ophthalmol. 2012;96(9):1252–8.PubMedCentralPubMedCrossRef Tan XW, Riau A, Shi ZL, Tan AC, Neoh KG, Khor KA, et al. In vitro effect of a corrosive hostile ocular surface on candidate biomaterials for keratoprosthesis skirt. Br J Ophthalmol. 2012;96(9):1252–8.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Singh R, Dahotre NB. Corrosion degradation and prevention by surface modification of biometallic materials. J Mater Sci Mater Med. 2007;18(5):725–51.PubMedCrossRef Singh R, Dahotre NB. Corrosion degradation and prevention by surface modification of biometallic materials. J Mater Sci Mater Med. 2007;18(5):725–51.PubMedCrossRef
25.
Zurück zum Zitat Green JM, Hallab NJ, Liao YS, Narayan V, Schwarz EM, Xie C. Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model. Curr Rheumatol Rep. 2013;15(5):325. Green JM, Hallab NJ, Liao YS, Narayan V, Schwarz EM, Xie C. Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model. Curr Rheumatol Rep. 2013;15(5):325.
26.
Zurück zum Zitat Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28(8):896–901.PubMedCrossRef Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28(8):896–901.PubMedCrossRef
27.
Zurück zum Zitat Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999;67(7):3348–56.PubMedCentralPubMed Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999;67(7):3348–56.PubMedCentralPubMed
28.
Zurück zum Zitat Kaper HJ, Busscher HJ, Norde W. Characterization of poly(ethylene oxide) brushes on glass surfaces and adhesion of Staphylococcus epidermidis. J Biomater Sci Polym Ed. 2003;14(4):313–24.PubMedCrossRef Kaper HJ, Busscher HJ, Norde W. Characterization of poly(ethylene oxide) brushes on glass surfaces and adhesion of Staphylococcus epidermidis. J Biomater Sci Polym Ed. 2003;14(4):313–24.PubMedCrossRef
29.
Zurück zum Zitat Kingshott P, Wei J, Bagge-Ravn D, Gadegaard N, Gram L. Covalent attachment of poly(ethylene glycol) to surfaces, critical for reducing bacterial adhesion. Langmuir. 2003;19:6912–21.CrossRef Kingshott P, Wei J, Bagge-Ravn D, Gadegaard N, Gram L. Covalent attachment of poly(ethylene glycol) to surfaces, critical for reducing bacterial adhesion. Langmuir. 2003;19:6912–21.CrossRef
Metadaten
Titel
Causes of sterile vitritis in the setting of Boston keratoprosthesis
verfasst von
Christina M. Grassi
James Chodosh, MD, MPH
Publikationsdatum
01.12.2014
Verlag
Springer Vienna
Erschienen in
Spektrum der Augenheilkunde / Ausgabe 6/2014
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI
https://doi.org/10.1007/s00717-014-0231-8

Weitere Artikel der Ausgabe 6/2014

Spektrum der Augenheilkunde 6/2014 Zur Ausgabe

editorial

Editorial

9th KPro Meeting 2014, abstracts

KPro Study Group 9th KPro Meeting